Kyverna Therapeutics, Inc. (KYTX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Kyverna Therapeutics, Inc. (KYTX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 36/100 — a percentile rank of Kyverna Therapeutics, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $403.2M |
| EV / EBITDA | -2.5× |
| Return on equity | -92.2% |
| ROIC | -100.1% |
| Debt / equity | 0.1× |
| Dividend yield | 0.0% |
Independent of the events above — derived from Kyverna Therapeutics, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact